Low dose aspirin reduced long-term incidence and mortality from colorectal cancer
- Aspirin reduced colorectal cancer recurrence in those with PIK3CA mutations. // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p26
The article discusses a research study published in the 2013 issue of the "Journal of Clinical Oncology" which found that low-dose aspirin reduces colorectal cancer recurrence in patients with PIK3CA gene mutations.
- A Hematological Malignancy. Pelino, Carlo J.; Pizzimenti, Joseph J. // Review of Optometry;11/15/2009, Vol. 146 Issue 11, p78
The article presents a case study of a 69-year old black female patient who was referred for an ophthalmic evaluation due to progressive bilateral visual blur. It notes that the patient was diagnosed with multiple myeloma, an incurable cancer that is described by malignant B cells' proliferation...
- Aspirin/caffeine/metformin. // Reactions Weekly;1/29/2011, Issue 1336, p9
The article describes the case of a 41-year-old woman who experienced fixed drug eruptions while receiving treatment with aspirin/caffeine for pain and metformin for type 2 diabetes.
- Aspirin/caffeine/salicylamide. // Reactions Weekly;1/29/2011, Issue 1336, p9
The article describes the case of a 41-year-old man who presented with sepsis-associated c-ANCA pauci-immune focal necrotising glomerulonephritis while receiving treatment with aspirin/caffeine/salicylamide, containing the excipient silicon dioxide.
- Alendronic acid/aspirin/ferrous sulfate. // Reactions Weekly;10/23/2010, Issue 1324, p8
The article describes the case of an 80-year-old woman who was diagnosed with an intramural haematoma of the esophagus while taking alendronic acid, aspirin and ferrous sulfate.
- Aspirin abuse. // Reactions Weekly;9/18/2010, Issue 1319, p10
The article describes the case of a 33-year-old woman who was diagnosed with haematoma and was revealed to have taken over-the-counter medication containing aspirin.
- Aspirin/nonsteroidal anti-inflammatories. // Reactions Weekly;12/18/2010, Issue 1332, p12
The article describes the case of a 38-year-old man who developed recurrent hypersensitivity with symptoms like respiratory dysfunction, urticaria and/or angioedema, after treatment with aspirin or nonsteroidal anti-inflammatories, referencing a study presented at the 2010 Annual Meeting of the...
- Aspirin cuts risk of colorectal cancer. Tanday, Sanjay // GP: General Practitioner;5/18/2007, p13
The article reports on the findings of the study regarding the effectiveness of aspirin to treat colorectal cancer conducted by researchers in Great Britain. The research suggested that general practitioners (GPs) should advise patients at high risk of developing colorectal cancer to take 300...
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Ogino, S; Lochhead, P; Giovannucci, E; Meyerhardt, J A; Fuchs, C S; Chan, A T // Oncogene;6/5/2014, Vol. 33 Issue 23, p2949
Regular use of aspirin reduces incidence and mortality of various cancers, including colorectal cancer. Anticancer effect of aspirin represents one of the 'Provocative Questions' in cancer research. Experimental and clinical studies support a carcinogenic role for PTGS2 (cyclooxygenase-2), which...